Longeveron Inc. (LGVN) shareholders
Close on Nov 18, 2026Market cap $61.21MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (9.00%), Daniel B. Asher (9.00%) | 2,941,180 | 9.00% | 13G (passive) amendment | Jun 30, 2026 |
| Mitchell P. Kopin Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%) | 2,143,418 | 9.99% | 13G (passive) | Aug 8, 2025 |
| Millennium Management LLC Joint filing with Integrated Core Strategies (US) LLC (5.20%), Millennium Group Management LLC (5.20%) and 1 more | 1,553,642 | 5.20% | 13G (passive) | Aug 4, 2026 |
| Janus Henderson Group PLC | 1,291,331 | 5.90% | 13G (passive) | Mar 31, 2026 |
| Joshua M. Hare, M.D | 1,084,888 | 25.70% | 13D (active) amendment | Apr 10, 2024 |
| Logos Global Management GP LLC Joint filing with Logos Global Management LP (6.30%), Logos Opportunities Fund V LP (6.30%) and 3 more | 192,308 | 6.30% | 13G (passive) | Sep 2, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LGVN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Millennium Management LLC | 135,388 | 0.42% | $951.78K | +90,715 | 0.00% |
| Logos Global Management LP | 128,700 | 0.40% | $904.76K | New | 0.04% |
| Vanguard Capital Management LLC | 58,131 | 0.18% | $408.66K | +3,928 | 0.00% |
| BlackRock, Inc. | 22,417 | 0.07% | $157.59K | −3 | 0.00% |
| Geode Capital Management, LLC | 20,376 | 0.06% | $143.24K | +14 | 0.00% |
| Jane Street Group, LLC | 19,037 | 0.06% | $133.83K | +471 | 0.00% |
| Vanguard Fiduciary Trust Co | 14,013 | 0.04% | $98.51K | +10,141 | 0.00% |
| Mariner, LLC | 12,600 | 0.04% | $88.58K | New | 0.00% |
| ADAR1 Capital Management, LLC | 10,841 | 0.03% | $76.21K | −9,159 | 0.00% |
| Beacon Pointe Advisors, LLC | 10,000 | 0.03% | $70.30K | – | 0.00% |
| Virtu Financial LLC | 5,858 | 0.02% | $41.00K | New | 0.00% |
| Two Sigma Securities, LLC | 5,597 | 0.02% | $39.35K | New | 0.00% |
| State Street Corp | 4,538 | 0.01% | $31.90K | – | 0.00% |
| Northern Trust Corp | 4,330 | 0.01% | $30.44K | +2,352 | 0.00% |
| Scotia Capital Inc. | 3,000 | 0.01% | $21.09K | New | 0.00% |
| Capital Investment Advisory Services, LLC | 2,653 | 0.01% | $18.65K | – | 0.00% |
| Commonwealth Equity Services, LLC | 2,516 | 0.01% | $17.68K | – | 0.00% |
| Hamilton Point Investment Advisors, LLC | 2,245 | 0.01% | $15.78K | – | 0.00% |
| Moneta Group Investment Advisors LLC | 2,130 | 0.01% | $14.97K | – | 0.00% |
| XTX Topco Ltd | 2,056 | 0.01% | $14.45K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 39 | 0M | 1.5% | 14 / 7 | 3 / 5 | 0M | 0M |
| Q1 2026 | 31 | 0M | 0.7% | 11 / 3 | 3 / 9 | 0M | 0M |
| Q4 2025 | 30 | 0M | 0.3% | 6 / 3 | 6 / 3 | 0M | 0M |
| Q3 2025 | 27 | 0M | 0.3% | 9 / 3 | 2 / 4 | 0M | 0M |
| Q2 2025 | 22 | 0M | 0.2% | 6 / 4 | 2 / 2 | 0M | 0M |
| Q1 2025 | 18 | 0M | 0.2% | 2 / 4 | 5 / 6 | 0M | 0M |
| Q4 2024 | 22 | 0M | 0.2% | 10 / 4 | 2 / 5 | 0M | 0M |
| Q3 2024 | 17 | 0M | 0.1% | 7 / 4 | 1 / 8 | 0M | 0M |
| Q2 2024 | 19 | 0M | 0.1% | 10 / 4 | 3 / 3 | 0M | 0M |
| Q1 2024 | 12 | 0M | 0.0% | 12 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joshua Hare | Chief Scientific Officer, Director, 10% owner | 10,811,369 | 33.91% | Aug 21, 2026 |
| Nirav S. Jhaveri | Chief Financial Officer | 29,258 | 0.09% | Oct 5, 2026 |
| Paul T. Lehr | General Counsel, Secretary | 226,295 | 0.71% | Oct 5, 2026 |
| Stephen H. Willard | Chief Executive Officer | 74,916 | 0.23% | Oct 5, 2026 |
| Nataliya Agafonova | Chief Medical Officer | 89,564 | 0.28% | Oct 5, 2026 |
| Devin Blass | CTO & SVP of CMC | 68,653 | 0.22% | Oct 5, 2026 |
| Marie Washburn | Chief Financial Officer | 101,030 | 0.32% | Jul 21, 2026 |
| Lisa Locklear | Chief Financial Officer | 480,005 | 1.51% | Jul 6, 2026 |
| James Nathaniel Powell | Chief Executive Officer | 125,593 | 0.39% | Jan 6, 2026 |
| Mohamed Wa'el Ahmed Hashad | Chief Executive Officer | 543,547 | 1.70% | Jul 17, 2025 |
| Roger Joseph Hajjar | Director | 69,000 | 0.22% | Aug 21, 2026 |
| Leah Rush Cann | Director | 36,000 | 0.11% | Aug 21, 2026 |
| Deborah Ascheim | Director | 36,000 | 0.11% | Aug 21, 2026 |
| George A. Paletta Jr. | Director | 70,000 | 0.22% | Aug 21, 2026 |
| Arjun JJ Desai | Director | 36,000 | 0.11% | Aug 21, 2026 |
| Ursula Ungaro | Director | 77,000 | 0.24% | Aug 21, 2026 |
| Rock Soffer | Director | 964,385 | 3.02% | Aug 21, 2026 |
| Khoso Baluch | Director | 67,391 | 0.21% | Aug 13, 2025 |
| Richard N. Kender | Director | 33,000 | 0.10% | Jul 17, 2025 |
| Neha J. Motwani | Director | 33,000 | 0.10% | Jul 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Nirav S. Jhaveri Chief Financial Officer | Oct 1, 2026 | Tax withholding | −742 | $2.59 | $1.92K | 29,258 |
| Stephen H. Willard Chief Executive Officer | Oct 1, 2026 | Tax withholding | −1,987 | $2.59 | $5.15K | 74,916 |
| Nataliya Agafonova Chief Medical Officer | Oct 1, 2026 | Tax withholding | −2,913 | $2.59 | $7.54K | 68,778 |
| Paul T. Lehr General Counsel, Secretary | Oct 1, 2026 | Tax withholding | −2,253 | $2.59 | $5.84K | 83,889 |
| Devin Blass CTO & SVP of CMC | Oct 1, 2026 | Tax withholding | −2,520 | $2.59 | $6.53K | 68,653 |
| Paul T. Lehr General Counsel, Secretary | Aug 19, 2026 | Award | +286,000 | – | – | 861,423 |
| Joshua Hare Chief Scientific Officer, Director, 10% owner | Aug 19, 2026 | Award | +286,000 | – | – | 1,607,796 |
| Rock Soffer Director | Aug 19, 2026 | Award | +36,000 | – | – | 262,034 |
| Roger Joseph Hajjar Director | Aug 19, 2026 | Award | +36,000 | – | – | 69,000 |
| Ursula Ungaro Director | Aug 19, 2026 | Award | +36,000 | – | – | 77,000 |
| Devin Blass CTO & SVP of CMC | Aug 19, 2026 | Award | +286,000 | – | – | 711,735 |
| Arjun JJ Desai Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| George A. Paletta Jr. Director | Aug 19, 2026 | Award | +36,000 | – | – | 70,000 |
| Nataliya Agafonova Chief Medical Officer | Aug 19, 2026 | Award | +286,000 | – | – | 716,914 |
| Deborah Ascheim Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| Leah Rush Cann Director | Aug 19, 2026 | Award | +36,000 | – | – | 36,000 |
| Nirav S. Jhaveri Chief Financial Officer | Aug 17, 2026 | Award | +300,000 | – | – | 300,000 |
| Joshua Hare Chief Scientific Officer, Director, 10% owner | Jul 6, 2026 | Award | +600,000 | – | – | 1,321,796 |
| Stephen H. Willard Chief Executive Officer | Jul 1, 2026 | Tax withholding | −18,046 | $0.73 | $13.17K | 771,681 |
| Devin Blass CTO & SVP of CMC | Jul 1, 2026 | Tax withholding | −15,808 | $0.73 | $11.54K | 425,735 |
| Paul T. Lehr General Counsel, Secretary | Jul 1, 2026 | Tax withholding | −13,143 | $0.73 | $9.59K | 575,423 |
| Lisa Locklear Chief Financial Officer | Jul 1, 2026 | Tax withholding | −22,505 | $0.73 | $16.43K | 443,181 |
| Nataliya Agafonova Chief Medical Officer | Jul 1, 2026 | Tax withholding | −22,505 | $0.73 | $16.43K | 430,914 |
| Paul T. Lehr General Counsel, Secretary | May 1, 2026 | Award | +250,000 | – | – | 588,566 |
| Stephen H. Willard Chief Executive Officer | May 1, 2026 | Award | +500,000 | – | – | 789,727 |
| Nataliya Agafonova Chief Medical Officer | May 1, 2026 | Award | +250,000 | – | – | 453,419 |
| Lisa Locklear Chief Financial Officer | May 1, 2026 | Award | +250,000 | – | – | 465,686 |
| Devin Blass CTO & SVP of CMC | May 1, 2026 | Award | +250,000 | – | – | 441,543 |
| Nataliya Agafonova Chief Medical Officer | Apr 1, 2026 | Tax withholding | −13,145 | $1.12 | $14.72K | 203,419 |
| Paul T. Lehr General Counsel, Secretary | Apr 1, 2026 | Tax withholding | −5,611 | $1.12 | $6.28K | 338,566 |
| Lisa Locklear Chief Financial Officer | Apr 1, 2026 | Tax withholding | −13,145 | $1.12 | $14.72K | 215,686 |
| Stephen H. Willard Chief Executive Officer | Apr 1, 2026 | Tax withholding | −4,740 | $1.12 | $5.31K | 289,727 |
| Devin Blass CTO & SVP of CMC | Apr 1, 2026 | Tax withholding | −8,633 | $1.12 | $9.67K | 191,543 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Tax withholding | −105,533 | $0.55 | $58.04K | 94,467 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Award | +200,000 | – | – | 200,000 |
| Stephen H. Willard Chief Executive Officer | Mar 2, 2026 | Award | +200,000 | – | – | 294,467 |
| James Nathaniel Powell Chief Executive Officer | Jan 2, 2026 | Tax withholding | −2,464 | $0.59 | $1.45K | 125,593 |
| Paul T. Lehr General Counsel, Secretary | Jan 2, 2026 | Tax withholding | −6,952 | $0.59 | $4.10K | 344,177 |
| Lisa Locklear Chief Financial Officer | Jan 2, 2026 | Tax withholding | −10,250 | $0.59 | $6.05K | 228,831 |
| Devin Blass CTO & SVP of CMC | Jan 2, 2026 | Tax withholding | −10,700 | $0.59 | $6.31K | 200,176 |
| Nataliya Agafonova Chief Medical Officer | Jan 2, 2026 | Tax withholding | −10,250 | $0.59 | $6.05K | 216,564 |
| George A. Paletta Jr. Director | Oct 1, 2025 | Award | +34,000 | – | – | 34,000 |
| James Nathaniel Powell Chief Executive Officer | Oct 1, 2025 | Tax withholding | −2,389 | $0.74 | $1.77K | 128,057 |
| Devin Blass CTO & SVP of CMC | Oct 1, 2025 | Tax withholding | −7,609 | $0.74 | $5.63K | 210,876 |
| Nataliya Agafonova Chief Medical Officer | Oct 1, 2025 | Tax withholding | −11,883 | $0.74 | $8.79K | 226,814 |
| Lisa Locklear Chief Financial Officer | Oct 1, 2025 | Tax withholding | −11,883 | $0.74 | $8.79K | 239,081 |
| Paul T. Lehr General Counsel, Secretary | Oct 1, 2025 | Tax withholding | −4,944 | $0.74 | $3.66K | 351,129 |
| James Nathaniel Powell Chief Executive Officer | Sep 4, 2025 | Award | +50,000 | – | – | 130,446 |
| Khoso Baluch Director | Aug 11, 2025 | Buy | +11,766 | – | – | 52,516 |
| Lisa Locklear Chief Financial Officer | Aug 11, 2025 | Buy | +11,766 | – | – | 250,964 |
| Rock Soffer Director | Jul 15, 2025 | Award | +17,000 | – | – | 226,034 |
| Lisa Locklear Chief Financial Officer | Jul 15, 2025 | Award | +102,000 | – | – | 239,198 |
| Roger Joseph Hajjar Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Richard N. Kender Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Neha J. Motwani Director | Jul 15, 2025 | Award | +17,000 | – | – | 33,000 |
| Paul T. Lehr General Counsel, Secretary | Jul 15, 2025 | Award | +102,000 | – | – | 356,073 |
| Nataliya Agafonova Chief Medical Officer | Jul 15, 2025 | Award | +102,000 | – | – | 238,697 |
| Ursula Ungaro Director | Jul 15, 2025 | Award | +17,000 | – | – | 41,000 |
| Khoso Baluch Director | Jul 15, 2025 | Award | +17,000 | – | – | 40,750 |
| Mohamed Wa'el Ahmed Hashad Chief Executive Officer | Jul 15, 2025 | Award | +180,000 | – | – | 420,904 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Longeveron's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,970 shares on Sep 17, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rock Soffer Director | May 29, 2025 | 21,000 | $26.78K | May 29, 2025 | Purchase - Pre-IPO |
| Joshua Hare Officer, Director | May 15, 2025 | 5,250 | $7.22K | May 15, 2025 | Founder's Equity |
| Khoso Baluch Director | Nov 27, 2024 | 1,250 | $2.58K | Nov 27, 2024 | Open Market Purchase |
See a number that looks wrong?